Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh
Non-Opioid Post-Operative Pain Management Using Bupivacaine-loaded Poly(ester urea) Mesh
批准号:
10322523
负责人:
Jiayi Yu
金额:
$173.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-13 至 2023-08-31
关键词:
Absence of pain sensationAcuteAcute PainAddressAdhesionsAmbulatory Surgical ProceduresAmino AcidsAnimalsBupivacaineCardiotoxicityClinical TrialsCyclic GMPDataDevelopmentDoseDrug Delivery SystemsDrug KineticsEstersExposure toFilmFormulationGoalsHerniaHourHydrocodoneImplantIn VitroInflammatory ResponseInjuryIntravenousKineticsLabelLeadLicensingLimb structureLocal AnestheticsMedical DeviceModelingMonitorMotorMusNon-Steroidal Anti-Inflammatory AgentsOperative Surgical ProceduresOpiate AddictionOpioidOralOrthopedicsOxycodonePainPain managementPatientsPharmaceutical PreparationsPhasePolyestersPolymersPostoperative PainPostoperative PeriodProceduresProduct ApprovalsProviderPublic HealthRecoveryReportingResidual stateRiskSafetySiteSourceSterilizationSurgeonSystemTherapeuticThickTimeTissuesToxic effectTraumaUnited StatesUreaWorkaddictionbasebiodegradable polymerchronic pain managementcombatcommercializationcontrolled releasecopolymerdiabeticdosagedrug efficacydrug release kineticsdrug release profileexperimental studyfirst-in-humanhigh riskimprovedin vivoinnovationinnovative technologiesmechanical allodyniamouse modelnon-opioid analgesicnovel strategiesoperationopioid epidemicopioid overuseopioid policyopioid useopioid use disorderpain modelpain reliefpainful neuropathyprescription opioidrepairedsafety assessmentsciatic nervesoft tissuestandard of carestemstoichiometry
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
21MedTech, LLC is developing SERENZATM, a non-opioid analgesic that is released from a bioresorbable film
for post-surgical pain management. Post-surgical pain management is a significant contributor to the risk for
opioid addiction and diversion. There were nearly 129 million outpatient surgeries in the U.S. in 2018 and
orthopedic surgeons alone account for nearly 8% of all opioid prescriptions in the U.S. Though the risk for
addiction and diversion is high, there are currently few alternative options to opioids for the management of post-
surgical pain and new approaches are needed to reduce patient exposure to these drugs and improve the
ongoing opioid crisis. There have been several products and therapies attempting to provide non-opioid
postoperative pain relief, but these products only work for 24 to 48 hours, despite claims otherwise, and others
still require additional rescue medication. To meet this urgent need, we are developing SERENZA. SERENZA is
a polymer film loaded with local anesthetic that is implanted at the surgical site following operation. Tunable
formulation of the film and loading enable control over local release for pain relief for up to four days following
surgery. The polymer film is bioresorbable and safely degrades over time. We have demonstrated safety of our
polymer film carrier, efficacy of the drug, and proof-of-concept of our system in vivo. Our Phase II objectives are
to optimize drug release kinetics and develop manufacturing standards, determine effective dosage for retention
of motor function, and determine safety and efficacy in mouse neuropathic pain models. Completion of these
goals will progress SERENZA toward first in-human clinical trials and successful FDA approval. Successful
approval and commercialization of SERENZA will enable a powerful new strategy for providers to reduce or
potentially eliminate the use of opioids and the risk of opioid use disorder for patients following surgery.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Application of surface-layer matrix-assisted laser desorption/ionization mass spectrometry imaging to pharmaceutical-loaded poly(ester urea) films.
表层基质辅助激光解吸/电离质谱成像在载药聚(酯脲)薄膜中的应用。
DOI:
10.1016/j.aca.2023.341963
发表时间:
2023
期刊:
Analytica chimica acta
影响因子:
6.2
作者:
[Williams-Pavlantos,Kayla, Brigham-Stinson,NatashaC, Becker,MatthewL, Wesdemiotis,Chrys]
通讯作者:
Wesdemiotis,Chrys
ARRAY: A novel polymeric mesh for prophylactic antibiotic protection of cardiac implantable electronic devices
-
批准号:10600803
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2023
-
负责人:Jiayi Yu
-
依托单位:
海外基金